(Q47579873)

English

Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin (English)

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

0 references

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

author name string

Morrell Michael Avram

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Daniel Blaustein

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Naveen Goel

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Jyotiprakas Chattopadhyay

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Neal Mittman

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Paul A. Fein

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531767

19 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14531767

19 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

full work available at URL

http://www.kidney-international.org/article/S008525381549636X/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531767

19 March 2024

https://api.elsevier.com/content/article/PII:S008525381549636X?httpAccept=text/xml

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

https://api.elsevier.com/content/article/PII:S008525381549636X?httpAccept=text/plain

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Kidney International. Supplement

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

S6-11

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

87

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Anemia of end-stage renal disease (ESRD).

1

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

2

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

3

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Markers for survival in dialysis: a seven-year prospective study

5

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years.

6

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters.

7

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

8

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation

10

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival

11

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients

12

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Nonparametric Estimation from Incomplete Observations

13

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones

14

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The Hemodynamic Response to Chronic Anemia

15

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Pathophysiology of anaemia: focus on the heart and blood vessels

16

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia

17

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin

19

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Influence of target hemoglobin in dialysis patients on morbidity and mortality.

20

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.

21

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

22

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?

23

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

24

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

25

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

26

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin

27

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Anemia: not just an innocent bystander?

29

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease

31

1 reference

10.1046/J.1523-1755.64.S87.3.X

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.3.X

19 March 2024

Identifiers

10.1046/J.1523-1755.64.S87.3.X

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14531767

19 March 2024

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/14531767

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47579873&oldid=2105422777"